Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | TACR1 | P25103 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10327286 | 0.83 | CYP1A2 (0.57) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL23791026 | 0.83 | CYP2D6 (0.57) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL2576834 | 0.83 | CYP1A2 (0.57) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL10326847 | 0.83 | CYP1A2 (0.57) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL1447193 | 0.80 | CYP2D6 (0.56) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL2574515 | 0.80 | CYP2D6 (0.56) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL12410019 | 0.80 | CYP1A2 (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL3004482 | 0.80 | CYP2D6 (0.56) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL23480058 | 0.80 | CYP2D6 (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL18943754 | 0.80 | CYP1A2 (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512041-B2 | Highly enantioselective access to cyclic beta-amino acids | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-11-29 | — | — | US | disclosed |
| US-20210171436-A1 | HIGHLY ENANTIOSELECTIVE ACCESS TO CYCLIC BETA-AMINO ACIDS | UNIV NANYANG TECH (SG) | 2021-06-10 | — | — | US | disclosed |
| EP-3599246-A1 | MEANS AND METHODS FOR SYNTHESIZING PRECURSORS OF Y-AMINOBUTYRIC ACID (GABA) ANALOGS | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2020-01-29 | — | — | EP | disclosed |
| US-9593071-B2 | Process for the preparation of gamma amino acids and intermediates used in said process | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2017-03-14 | — | — | US | disclosed |
| US-20160229778-A1 | DIRECT B-ARYLATION OF CARBONYL COMPOUNDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2016-08-11 | — | — | US | disclosed |
| EP-2703381-B1 | METHOD FOR PRODUCING FIVE-MEMBERED RING-CONTAINING COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2015-10-21 | — | — | EP | disclosed |
| CN-104220433-A | Process for preparing gamma amino acids and intermediates useful in said process | ROYAL COLLEGE OF SURGEONS IE | 2014-12-17 | — | — | CN | disclosed |
| US-20140336412-A1 | PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2014-11-13 | — | — | US | disclosed |
| EP-2782911-A1 | PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS | Royal College of Surgeons in Ireland (IE) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013189978-A1 | PROCESS FOR PREPARING ß-AMINO ACID DERIVATIVES AND USE OF SAID PROCESS FOR PREPARING TELAPREVIR | SANDOZ AG (CH) | 2013-12-27 | — | — | WO | disclosed |
| WO-2013076225-A1 | PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2013-05-30 | — | — | WO | disclosed |
| US-20110172438-A1 | Enantioselective Cascade Michael-Michael Reactions and Related Catalysts | NATIONAL SCIENCE FOUNDATION | 2011-07-14 | — | — | US | disclosed |
| WO-2010027510-A2 | ENANTIOSELECTIVE CASCADE MICHAEL-MICHAEL REACTIONS AND RELATED CATALYSTS | STC. UNM (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172438-A1 | Enantioselective Cascade Michael-Michael Reactions and Related Catalysts | FASN, PTGES, CBS | CYP2D6 1882/4885CYP1A2 623/4885CYP2C19 856/4885 |
| US-11512041-B2 | Highly enantioselective access to cyclic beta-amino acids | BCAT1, BCAT2, SLC7A1 | CYP2D6 1188/4885CYP1A2 721/4885CYP2C19 1043/4885 |
| US-20210171436-A1 | HIGHLY ENANTIOSELECTIVE ACCESS TO CYCLIC BETA-AMINO ACIDS | BCAT1, BCAT2, SLC7A1 | CYP2D6 1188/4885CYP1A2 721/4885CYP2C19 1043/4885 |
| US-20160229778-A1 | DIRECT B-ARYLATION OF CARBONYL COMPOUNDS | DBH, DDT, CBR3 | CYP2D6 103/4885CYP1A2 310/4885CYP2C19 781/4885 |
| US-20140336412-A1 | PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS | GLRB, GABRP, GABRG1 | CYP2D6 70/4885CYP1A2 123/4885CYP2C19 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.